Literature DB >> 25696267

'White elephants' and a distinguished monkey - or the need for a proactive follow-up in amiodarone therapy.

Chr van Tellingen.   

Abstract

Two patients presented with a rather unusual form and documentation of amiodarone toxicity. General aspects on this topic are addressed with emphasis on neurotoxicity and pulmonary disease. The need for rational prescribing and a scrupulous follow-up is stressed in view of apparent unawareness of general physicians and organ-related specialists alike regarding these very phenomena.

Entities:  

Keywords:  amiodarone; neurotoxicity; pulmonary toxicity

Year:  2004        PMID: 25696267      PMCID: PMC2497164     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  9 in total

1.  Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart.

Authors:  W F Lubbe; M L McFadyen; C A Muller; M Worthington; L H Opie
Journal:  Am J Cardiol       Date:  1979-03       Impact factor: 2.778

Review 2.  New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.

Authors:  D P Zipes; P J Troup
Journal:  Am J Cardiol       Date:  1978-05-22       Impact factor: 2.778

3.  Unusual neurotoxicity associated with amiodarone therapy.

Authors:  P R Palakurthy; V Iyer; R J Meckler
Journal:  Arch Intern Med       Date:  1987-05

Review 4.  Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.

Authors:  C M Newman; A Price; D W Davies; T A Gray; A P Weetman
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

5.  Amiodarone induced optic neuropathy.

Authors:  P K Nagra; R Foroozan; P J Savino; I Castillo; R C Sergott
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

6.  [Amiodaron neuropathy: clinical and pathological study of a new drug induced lipidosis (author's transl)].

Authors:  P Dudognon; J J Hauw; C de Baecque; J P Derrida; R Escourolle; E J Nick
Journal:  Rev Neurol (Paris)       Date:  1979 Jul-Aug       Impact factor: 2.607

Review 7.  Optimal management of amiodarone therapy: efficacy and side effects.

Authors:  D Hilleman; M A Miller; R Parker; P Doering; J A Pieper
Journal:  Pharmacotherapy       Date:  1998 Nov-Dec       Impact factor: 4.705

8.  Optic nerve ultrastructure following amiodarone therapy.

Authors:  A M Mansour; J E Puklin; R O'Grady
Journal:  J Clin Neuroophthalmol       Date:  1988-12

9.  High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.

Authors:  M I Anastasiou-Nana; J L Anderson; J N Nanas; J R Lutz; R A Smith; K P Anderson; R O Crapo; N B Call
Journal:  Can J Cardiol       Date:  1986 May-Jun       Impact factor: 5.223

  9 in total
  1 in total

1.  Suspension of disbelief - or the Bumetanide paradox.

Authors:  C van Tellingen
Journal:  Neth Heart J       Date:  2007-01       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.